Back to DE D. E. Shaw & Co., Inc.

VKTXVKTX
26 quarters

Position history for DED. E. Shaw & Co., Inc.'s holdings in VIKING THERAPEUTICS INC

D. E. Shaw & Co., Inc. holds 1.6M shares of VKTX (VIKING THERAPEUTICS INC), worth $62.6M as of 2026-Q2. The position was decreased (-4.2% shares). VKTX represents 0.0% of D. E. Shaw & Co., Inc.'s portfolio.

Current Value

$62.6M

Current Shares

1.6M

Total Value Change

+$62.5M

Total Shares Change

+1.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.6M
-4.2%
$62.6M0.0%$39.01
0
2026-Q1
Decreased
1.7M
-2.4%
$54.6M0.0%$31.93
0
2025-Q4
Increased
1.7M
+965.0%
$60.5M0.0%$35.32
48
2025-Q3
Decreased
161,357
-21.5%
$4.2M0.0%$25.81
0
2025-Q2
Decreased
205,473
-37.0%
$5.4M0.0%$26.52
0
2025-Q1
Increased
326,294
+219.1%
$7.9M0.0%$25.65
44
2024-Q4
Decreased
102,243
-77.6%
$4.1M0.0%$39.77
0
2024-Q3
Decreased
456,460
-13.1%
$28.9M0.0%$61.63
0
2024-Q2
Increased
525,502
+593.8%
$27.9M0.0%$53.01
46
2024-Q1
Decreased
75,742
-34.5%
$6.2M0.0%$82.00
0
2023-Q4
Increased
115,635
+34.5%
$2.2M0.0%$18.61
34
2023-Q3
Decreased
85,980
-74.0%
$951,7990.0%$11.07
0
2023-Q2
Decreased
330,922
-61.1%
$5.4M0.0%$15.62
0
2023-Q1
Decreased
850,055
-10.6%
$14.2M0.0%$17.33
0
2022-Q4
Increased
951,240
+6760.2%
$8.9M0.0%$9.40
44
2022-Q3
Decreased
13,866
-19.9%
$38,0000.0%$2.75
0
2022-Q2
Decreased
17,300
-90.2%
$50,0000.0%$2.77
0
2022-Q1
New
176,278
-
$529,0000.0%$3.05
33
2021-Q3
Exited
0
-100.0%
$00.0%$6.38
0
2021-Q2
Decreased
16,273
-15.4%
$97,0000.0%$6.16
0
2021-Q1
Decreased
19,239
-22.3%
$122,0000.0%$6.06
0
2020-Q4
Decreased
24,765
-58.2%
$139,0000.0%$5.84
0
2020-Q3
Decreased
59,257
-20.5%
$345,0000.0%$5.93
0
2020-Q2
Increased
74,517
+5.3%
$537,0000.0%$7.26
26
2020-Q1
Increased
70,798
+422.8%
$331,0000.0%$4.74
38
2019-Q4
New
13,541
-
$109,0000.0%$7.93
30

Other major holders of VKTX: BlackRock Finance, Inc., FMR LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used